Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.5300
-0.0061 (-1.14%)
At close: Oct 27, 2026
Kairos Pharma Employees
As of December 31, 2025, Kairos Pharma had 4 total employees, including 1 full-time and 3 part-time employees. The number of employees did not change compared to the previous year. That makes Kairos Pharma the 42,204th largest employer in the world and 6,634th in the United States.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,451,250
Market Cap
1.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 4 | 0 | - | 1 | 3 |
| Dec 31, 2024 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| PMGC Holdings | 34 |
| Curis | 24 |
| GeoVax Labs | 19 |
| BioRestorative Therapies | 14 |
| Genprex | 13 |
| Revelation Biosciences | 9 |
| Oragenics | 3 |
| Silo Pharma | 3 |
KAPA News
- 5 days ago - CEO.CA's Inside the Boardroom: Major U.S. Cancer Centers Are Testing This New Drug: Kairos Pharma - Newsfile Corp
- 7 days ago - Kairos Pharma Transcript: LD Micro 20th Annual Main Event Conference - Transcripts
- 21 days ago - Kairos Pharma announces interim efficacy data from Phase 2 trial of ENV-105 - TheFly
- 21 days ago - Kairos Pharma Reports Positive, Statistically Significant Interim Efficacy Data from Phase 2 Trial of ENV-105 in Metastatic Prostate Cancer - Business Wire
- 4 weeks ago - Kairos Pharma to Present and Moderate at Discovery on Target Conference in Boston, MA - Business Wire
- 6 weeks ago - Kairos Pharma Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - Kairos Pharma Slides: Investor presentation - Filings
- 6 weeks ago - Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Business Wire